In support of these findings, the results of the HeLiX trial revealed a nonsignificant trend toward a greater proportion of patients undergoing vascular reconstruction in the TXA group (3.4% vs. 2.6%).
← all excerpts
The value of tranexamic acid in liver resection should not be exaggerated or ignored.
1
—
—